Evidence map

TrialClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Biomarker Analysis from the Compass Claudication Study - Rivaroxaban for Intermittent Claudication.

Karen Falcão Britto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41129724